Get started
Work

OA15.03 Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS

Year: 2021
Type: article
DOI: 10.1016/j.jtho.2021.08.084
Authors: A. Spira, M. Krebs, B.C. Cho, B. Besse, J. Goldman, P. Janne, C.K. Lee, Z. Ma, A. Mansfield, A. Minchom, S. Ou, R. Salgia, Z. Wang, G. Gao, J. Curtin, A. Roshak, R. Schnepp, M. Thayu, R. Knoblauch, J.M. Trigo
Institutions: Virginia Cancer Specialists, Manchester Academic Health Science Centre, University of Manchester, The Christie NHS Foundation Trust, Yonsei University, Yonsei Cancer Hospital, Institut Gustave Roussy, University of California, Los Angeles, Dana-Farber Cancer Institute, St George Hospital, Henan Cancer Hospital, Mayo Clinic, Institute of Cancer Research, University of California, Irvine, City Of Hope National Medical Center, City of Hope, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Janssen Research & Development (United States), Hospital Clínico Universitario Virgen de la Victoria
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3206539120
FWCI: 2.277
Cites:
Cited by: 18
Related to: 10